Impact of Improvement in Renal Function and Waiting Time Before Induction Therapy on Survival in Newly Diagnosed Multiple Myeloma

Multiple myeloma (MM) is the second most common haematological malignancy among adults in Hungary. Renal impairment is frequent in MM patients and has fundamental impact on overall survival (OS). Our research question was how long the waiting time of patients is from the detection of renal impairment (GFR <40 mL/min) until the start of induction therapy and how this waiting time influences OS. We also studied if reversibility/irreversibility of renal failure has an impact on OS.